COPD Assessment Test Can Predict Depression

COPD Clinical Trial

Official title:

COPD Assessment Test Can Predict Depression

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01727219
• Other study ID #: 2011-I010
• Status: Not yet recruiting
• Phase: N/A
• First received: November 12, 2012
• Last updated: November 18, 2012
• Start date: December 2012
• Est. completion date: May 2013

Study information

• Verified date: February 2011
• Source: Hallym University Medical Center
• Contact: Sunghoon Park, Dr.
• Phone: 82-31-380-3803
• Email: f2000tj[@]gmail.com
• Is FDA regulated: No
• Health authority: Korea: Ministry for Health and Welfare
• Study type: Observational

Clinical Trial Summary

The frequency of depression in COPD patients are substantial and early detection and prevention of depression is critical.

Recently, COPD assessment test (CAT) was developed and validated to assess the impact of COPD on patients' quality of life.

In this prospective study, we will investigate the predictive utility of CAT for predicting depression in COPD patients.

Description:

This study is aimed to investigate the association between the COPD Assessment Test (CAT) and depression in stable COPD patients. Stable COPD patients will be enrolled from the tertiary hospitals. All patients will undergo lung function tests. The Korean versions of the CAT (COPD assessment test) and Patient Health Questionnaire-9 (PHQ-9) will be used to assess COPD symptoms and depressive disorder, respectively.

We will compare the depresssion frequency among GOLD classifications of airway limitation and among the four CAT groups. And. we will also investigate which items of the CAT are the strongest indicators of depression.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 600
• Est. completion date: May 2013
• Est. primary completion date: February 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• COPD patients who aged > or = 40 years

Exclusion Criteria:

• acute exacerbation within 3 months

• bronchial asthma or an increase in FEV1 of more than 12% of the predicted value with the use of 400 µg of albuterol.

• other lung diseases such as bronchiectasis, interstitial lung disease, and tuberculosis-destroyed lungs.

• who denied to consent.

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• COPD
• Depression
• Depression,
• Depressive Disorder

Locations

Country	Name	City	State
Korea, Republic of	Hallym University Sacred Heart Hospital, Department of Pulmonary, Critical Care Medicine	Anyang-	Gyeonggi-do

Sponsors (1)

Lead Sponsor	Collaborator
Hallym University Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The predictive utility of the COPD assessment test (CAT) scores for predicting depression in COPD patients	The association of CAT with depression score	1 year	No